sur DIAGNOSTIC MEDICAL (EPA:ALDMS)
Half-yearly review of the Diagnostic Medical Systems Liquidity Contract
On January 6, 2026, Diagnostic Medical Systems (DMS), a company listed on Euronext Growth Paris, published its half-year report for the liquidity contract managed by NATIXIS ODDO BHF since May 7, 2025. As of December 31, 2025, the liquidity account comprised 110,630 shares and 102,349 euros.
At the time the contract was established, the resources were 150,000 shares and 50,000 euros. Between July 1 and December 31, 2025, 1,155 purchase transactions and 1,153 sale transactions were carried out, representing 248,152 shares and 330,540 euros for purchases, and 253,627 shares and 342,117 euros for sales.
DMS's upcoming publications include 2025 annual revenue on January 19, annual results on April 14, and Q1 2026 revenue on April 21.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de DIAGNOSTIC MEDICAL